New Zealand Patent Office Issues Notice of Allowance for MDRNA Application

According to MDRNA, the application claims siRNAs and delivery systems with therapeutic potential.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories